Endocannabinoid System Research: Cannabis in HIV Care
Digital therapeutics HIV smoking cessation research shows strong feasibility and acceptability among people living with HIV. This approach offers scalable cessation tools for this high-risk population. Tobacco use remains a leading cause of illness and…
Cannabidiol for Lennox-Gastaut: Cannabinoid Clinical Trials
Clinically meaningful reduction in drop seizures has been observed in Lennox-Gastaut syndrome patients treated with cannabidiol. Clinical trials show that even reductions below 50% can improve patient quality of life. Caregiver-reported outcomes align…
Cannabinoid Clinical Trials: CBD Gel Safety in Fragile X
Transdermal cannabidiol gel fragile x syndrome safety data comes from ongoing clinical trials evaluating long-term tolerability in children and adolescents. This synthetic CBD formulation targets behavioral symptoms linked to endocannabinoid…
Cannabinoid Clinical Trials: CBD, WADA, and Urine Testing Insights
Broad-spectrum CBD supplements doping risk is a critical concern for athletes subject to anti-doping rules. This study found that daily use of broad-spectrum CBD can produce detectable WADA-prohibited cannabinoids in urine. Exercise further amplifies…
Topical Cannabis for AIMSS: Cannabinoid Clinical Trials
Topical cannabis balms for AIMSS were tested in a randomized trial for breast cancer patients experiencing joint pain from aromatase inhibitor therapy. The study assessed feasibility and safety of cannabinoid topical treatments. Results provide early…
Cannabinoid Clinical Trials: Cannabis Effects on Alcohol Urge
Working memory cannabis alcohol urge interactions reveal how cognitive capacity affects alcohol cravings after cannabis use. This clinical trial shows that individuals with higher working memory capacity experience reduced alcohol urge. These findings…
Review of Cannabis Derivatives in Autism Clinical Research
Cannabis derivatives autism clinical research shows preliminary benefits for symptoms like irritability and sleep difficulties. The evidence remains limited and requires cautious interpretation. Patients should consult clinicians before considering…
Endocannabinoid System & Trauma Sleep Research Findings
Pre-trauma insomnia posttraumatic alcohol cannabis use are closely linked in trauma survivors. This focus keyword highlights the risk of substance use following sleep disturbances before trauma. Clinicians should screen for insomnia to reduce…
Endocannabinoid System Research: CBD & Cortical Excitability
In a controlled crossover trial, cannabidiol lacks direct effect on cortical excitability compared to placebo. This suggests CBD’s anti-seizure benefits depend on interactions with medications like clobazam. Clinicians should consider this when…
Cannabinoid Clinical Trials: Oral Cannabis Effects on Sleep
This pilot trial examines the acute effects of oral cannabinoids on sleep in adults with insomnia. A single dose of THC combined with CBD reduced total sleep time, indicating no improvement in objective sleep. High-density EEG revealed changes in sleep…
